After Shift On Vaccine Patents, US Backs Freer Flow Of Components
Muhammad Irfan Published May 07, 2021 | 10:40 AM
Paris, May 7 (UrduPoint / Pakistan Point News - 7th May, 2021 ) :The new US position in support of lifting patents on Covid-19 vaccines has taken attention away from an equally significant change by Washington, which plans to open up trade in the raw materials used to make them.
After having recently taken heat for blocking such exports, Commerce Secretary Katherine Tai said Wednesday that the US government would "work to increase the raw materials needed to produce those vaccines".
The assertion was hidden at the bottom of the statement unveiling Washington's remarkable reversal of its position on Covid-19 vaccine patents, which coincides with a shortage of doses in emerging and developing nations as cases surge in some countries.
Long legal and economic policy debates likely lie ahead about waiving vaccine patents, particularly at the World Trade Organization (WTO).
Meanwhile, the difficulties faced by some laboratories in obtaining components to manufacture vaccines look set to stymie the drive to ramp up production.
Two labs have recently spoken out about their difficulties, laying the blame at Washington's door.
Germany's Curevac said it could not secure supplies of certain materials from the United States.
Several days earlier, India's Serum Institute, the world's largest vaccine manufacturer, called on US President Joe Biden to step in.
"Respected @POTUS, if we are to truly unite in beating this virus, on behalf of the vaccine industry outside the US, I humbly request you to lift the embargo of raw material exports out of the US so that vaccine production can ramp up," the company's president Adar Poonawalla wrote on Twitter.
There is no actual embargo on exporting vaccine components. Instead, Biden, like his predecessor Donald Trump, invoked the Defense Production Act -- which normally concerns wartime -- to confront the pandemic.
While it does not explicitly ban exports, it puts the US government first in line to buy certain products made in the country.
US officials have previously played down the possible effect of the law on global vaccine production.
"There's just more global manufacturing happening everywhere in the world than suppliers can currently support," a US official told a White House briefing late last month on condition of anonymity.
Related Topics
Recent Stories
HEC reviews curricula for environmental sciences degree programme
ICC Asia looking forward to an action-packed Asia Cricket Week
Yuvraj Singh named ICC Men’s T20 World Cup 2024 Ambassador
Greece hands Olympic flame to 2024 Paris Games hosts
Two Kyiv hospitals evacuating over feared Russian strikes
World must act on neurotech revolution, say experts
Charles & Catherine's cancer diagnoses
Champions Alcaraz and Sabalenka through in Madrid Open
King Charles to resume some public duties during cancer treatment: palace
US defense chief announces $6 bn in security aid for Ukraine
Heavy rains cause damage to Spezand-Taftan railway track
Woman stabbed in Israel, attacker killed: police
More Stories From Miscellaneous
-
Modern Education Techniques: A pathway to achieve economic development
15 hours ago -
Kite Flying: From cultural festival to deadly sport
15 hours ago -
PDMA predicts gusty wind, rain with thunder, hails
3 days ago -
Iranian president Raisi given guard of honour at PM House
5 days ago -
Intellectuals, writers accolades Naseer Mirza on his literary contribution
5 days ago -
Bahawalpur Adabi Sangat hosts memorable mushaira
5 days ago
-
Cattle farming vital to alleviate poverty in rural areas
5 days ago -
Pakistan: A land of tourism, archeological wonders
6 days ago -
Transforming education sector: from job hunters to job creators
8 days ago -
Amjad Bobby remembered on 19th death anniversary for timeless contributions to music
12 days ago -
Legendary actor Nadeem’s 26 films released on Eid-ul-Fitr days in 50 years
12 days ago -
Besant Hall Cultural Centre to celebrate evening with Sanam Marvi on 26 April
12 days ago